General Information of Drug (ID:
DR2963) |
Drug Name |
YM-992
|
Synonyms |
Lubazodone HCl; Lubazodone hydrochloride; Lubazodone hydrochloride [USAN]; YM992; Lubazodone (TN); Lubazodone hydrochloride (USAN); SM-50C; YM-35992; (2S)-2-[(7-fluoro-2,3-dihydro-1H-inden-4-yl)oxymethyl]morpholine hydrochloride; (S)-2-(((7-fluoro-4-indanyl)oxy)methyl)morpholine hydrochloride
|
Indication |
Depression
[ICD11: 6A70-6A7Z]
|
Discontinued in Phase 2
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
287.76 |
Topological Polar Surface Area |
30.5 |
Heavy Atom Count |
19 |
Rotatable Bond Count |
3 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
4 |
Cross-matching ID |
- PubChem CID
- 157918
- CAS Number
-
- TTD Drug ID
- D01ESB
- Formula
- C14H19ClFNO2
- Canonical SMILES
- C1CC2=C(C=CC(=C2C1)F)OC[C@@H]3CNCCO3.Cl
- InChI
- InChI=1S/C14H18FNO2.ClH/c15-13-4-5-14(12-3-1-2-11(12)13)18-9-10-8-16-6-7-17-10;/h4-5,10,16H,1-3,6-9H2;1H/t10-;/m0./s1
- InChIKey
- HWEMEKZYQCJVEZ-PPHPATTJSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.